HOME >> BIOLOGY >> NEWS
UB dental researchers find novel peptide in saliva that kills broad range of fungi and bacteria

SAN DIEGO -- A small piece of protein from one end of a larger molecule found in human saliva has been shown in laboratory tests to have potent antimicrobial activity against several types of bacteria and fungi, some of which are resistant to current drugs.

If these findings hold up in animal and human trials, the peptide, labeled MUC7 20-mer, could form the basis for promising new drugs for treating a wide range of infections, said Libuse Bobek, Ph.D., associate professor of oral biology in the University at Buffalo School of Dental Medicine and senior scientist on the research.

Results of the research were presented here today (March 8) at the International Association of Dental Research meeting.

"There is an increasing need for new antimicrobial agents, especially antifungals," said Bobek, "because there are only a handful of these drugs, they are used widely, and several fungal strains already have developed resistance. This is a particular problem for immuno-compromised patients, such as those with HIV/AIDS, organ transplant patients and chemotherapy patients."

This novel peptide, on which Bobek holds a provisional patent, has been shown in vitro to kill the fungal agents that cause the most common opportunistic infections that threaten these patients -- candidiasis, cryptococcosis and aspergillosis -- as well as several bacteria, including E. coli and P. gingivalis, which cause serious intestinal and oral infections, respectively, and S. mutans, which causes dental caries. Moreover, the peptide is active (in vitro) at very low concentrations -- 10 micrograms per milliliter -- shows little or no toxicity to mammalian cells and low tendency to elicit resistance, Bobek said.

"MUC-7 20-mer appears to be a very versatile agent, active at very low dosing, which works comparable to or better than current drugs," she said. "It has a different mechanism of action, but we don't know yet specifically what the mechanism is."

The re
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x 1417
University at Buffalo
8-Mar-2002


Page: 1 2

Related biology news :

1. Growing replacement teeth and dental tissues
2. Researchers say US military accidentally introduced tree pathogen to Italian estate
3. UMass anthropologist investigates dental development and body size in primates
4. Patch delivers longer, deeper relief from dental pain
5. UF dental researcher develops genetically altered bacteria strain that may fight cavities for a lifetime
6. Electronic dental anesthesia helps allay needle injection pain
7. Measures To Prevent Accidental Child Poisoning
8. Belgian researchers explore revolutionary approach to angiogenesis
9. Award winning researchers reveal potential new role for Glivec
10. $7.5 Million grant to Yale researchers for role of viruses in cancer
11. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: